Brief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
14/10/2026 22:02
BRIEF-Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors Oct 14 (Reuters) - Achieve Life Sciences, Inc. ACHV.O:
LISATA THERAPEUTICS APPOINTS JEFF FARROW TO BOARD OF DIRECTORS
LISATA THERAPEUTICS - BOARD EXPANDED FROM SEVEN TO EIGHT MEMBERS WITH NEWLY CREATED SEAT
Source text: ID:nGNX2dtbt
Further company coverage: ACHV.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)